Clever Leaves Holdings Inc (CLVR)
4.11
+0.24
(+6.14%)
USD |
NASDAQ |
Apr 26, 16:00
4.11
0.00 (0.00%)
After-Hours: 16:10
Clever Leaves Holdings Revenue (Quarterly): 4.638M for Dec. 31, 2023
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.638M |
| September 30, 2023 | 3.82M |
| June 30, 2023 | 4.981M |
| March 31, 2023 | 3.978M |
| December 31, 2022 | 4.402M |
| September 30, 2022 | 2.867M |
| June 30, 2022 | 4.10M |
| March 31, 2022 | 5.041M |
| Date | Value |
|---|---|
| December 31, 2021 | 4.194M |
| September 30, 2021 | 4.031M |
| June 30, 2021 | 3.672M |
| March 31, 2021 | 3.477M |
| December 31, 2020 | 3.347M |
| September 30, 2020 | 3.917M |
| June 30, 2020 | 1.939M |
| March 31, 2020 | 2.914M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
1.939M
Minimum
Jun 2020
5.041M
Maximum
Mar 2022
3.832M
Average
3.948M
Median
Revenue (Quarterly) Benchmarks
| Tilray Brands Inc | 188.34M |
| Flora Growth Corp | 17.98M |
| Acasti Pharma Inc | -- |
| Aurinia Pharmaceuticals Inc | 45.10M |
| Edesa Biotech Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.085M |
| Total Expenses (Quarterly) | 9.55M |
| EPS Diluted (Quarterly) | -2.95 |
| Enterprise Value | 1.182M |
| Gross Profit Margin (Quarterly) | -7.46% |
| Profit Margin (Quarterly) | -109.6% |
| Earnings Yield | -274.9% |
| Normalized Earnings Yield | -237.72 |